Efficacy and Safety of Intravenous Neridronic Acid in Complex Regional Pain Syndrome (CRPS)
Status:
Terminated
Trial end date:
2019-08-01
Target enrollment:
Participant gender:
Summary
The aim of this trial was to investigate the efficacy and safety of intravenous neridronic
acid in subjects with Complex Regional Pain Syndrome (CRPS).
The trial consisted of an Enrollment Period lasting up to 60 days, Treatment Period A
consisting of 4 infusions (neridronic acid 100 mg or placebo) over 10 days, and a Follow-up
Period 1 until Week 26. At Week 26, participants meeting the pre-specified criteria entered
the open-label Treatment Period B with 4 additional infusions (neridronic acid) over 10 days
and follow-up visits until Week 52. Participants not meeting the pre-specified criteria to
continue into Treatment Period B continued in Follow-up Period 2 until Week 52.